Table 2 Timing of sampling of patient specimens.

From: Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts

Period

Bangladesh

Japan

2021/12/25–2022/9/21

2020/6/14–2020/10/9

2020/10/10–2021/2/28

2021/3/1–2021/6/20

2021/6/21–2021/10/17

2021/12/26–2022/6/19

Wave in Japan

 

2nd wave

3rd wave

4th wave

5th wave

6th wave

Virus main variant

Omicron

Wuhan

Wuhan

Alpha

Delta

Omicron

Final outcome

 Mild: n (%)

64 (49.6)

3 (15.8)

19 (25.7)

11 (25.6)

10 (31.3)

8 (27.6)

 Moderate: n (%)

46 (35.7)

1 (5.3)

10 (13.5)

5 (11.6)

6 (18.8)

3 (10.3)

 Severe: n (%)

19 (14.7)

15 (78.9)

45 (60.8)

27 (62.8)

16 (50)

18 (62.1)

Total: n

129

19

74

43

32

29